These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15121066)

  • 1. ICD-implantation guidelines versus clinical practice: a prospective study of out-of-hospital cardiac arrest survivors.
    Sterk B; van Alem AP; Tukkie R; Simmers TA; Koster RW
    Europace; 2004 May; 6(3):179-83. PubMed ID: 15121066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Idiopathic ventricular fibrillation: from a collection of clinical cases to a prospective evaluation. The U-CARE Steering Committee. Unexplained Cardiac Arrest Registry of Europe].
    Priori SG; Paganini V; Boccalatte L; Schwartz PJ
    G Ital Cardiol; 1995 Feb; 25(2):149-58. PubMed ID: 7642019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
    J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary prevention of defibrillator implantation after myocardial infarction: clinical practice and compliance to guidelines.
    Sjöblom J; Ljung L; Frick M; Rosenqvist M; Frykman V
    Europace; 2012 Apr; 14(4):490-5. PubMed ID: 22117032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era.
    de Jong JS; Marsman RF; Henriques JP; Koch KT; de Winter RJ; Tanck MW; Wilde AA; Dekker LR
    Am Heart J; 2009 Sep; 158(3):467-72. PubMed ID: 19699872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term subjective memory function in ventricular fibrillation out-of-hospital cardiac arrest survivors resuscitated by early defibrillation.
    Bunch TJ; White RD; Smith GE; Hodge DO; Gersh BJ; Hammill SC; Shen WK; Packer DL
    Resuscitation; 2004 Feb; 60(2):189-95. PubMed ID: 15036737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation].
    Wierzbowski R; Michałkiewicz D; Cholewa M; Jacewicz K; Gniłka A; Adamus J
    Pol Merkur Lekarski; 2006 Oct; 21(124):310-3. PubMed ID: 17205766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of inducible ventricular flutter/fibrillation in risk stratification in patients with coronary artery disease.
    Matsushita T; Chun S; Liem LB; Friday KJ; Sung RJ
    Int J Cardiol; 2004 Mar; 94(1):67-71. PubMed ID: 14996477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of body weight with total mortality and with ICD shocks among survivors of ventricular fibrillation in out-of-hospital cardiac arrest.
    Bunch TJ; White RD; Lopez-Jimenez F; Thomas RJ
    Resuscitation; 2008 Jun; 77(3):351-5. PubMed ID: 18308453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ventricular fibrillation in chronic heart disease].
    Pleskot M; Parízek P; Hodac M; Haman L; Stásek J; Cervinka P; Tauchman M
    Vnitr Lek; 2000 Feb; 46(2):80-6. PubMed ID: 11048528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of implantable cardioverter defibrillators after out-of-hospital cardiac arrest: a prospective follow-up study.
    Parkash R; Tang A; Wells G; Blackburn J; Stiell I; Simpson C; Dorian P; Yee R; Cameron D; Connolly S; Birnie D; Nichol G
    CMAJ; 2004 Oct; 171(9):1053-6. PubMed ID: 15505267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quick-implantable-defibrillator trial.
    Bänsch D; Kottkamp H; Grönefeld G; Vogt J; Israel C; Böcker D; Hindricks G; Kuck KH;
    Europace; 2007 Dec; 9(12):1144-50. PubMed ID: 17913695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
    Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
    Rosso R; Glick A; Glikson M; Wagshal A; Swissa M; Rosenhek S; Shetboun I; Khalamizer V; Fuchs T; Boulos M; Geist M; Strasberg B; Ilan M; Belhassen B;
    Isr Med Assoc J; 2008 Jun; 10(6):435-9. PubMed ID: 18669142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of short- and long-term outcomes by electrocardiography in survivors of out-of-hospital cardiac arrest.
    Bunch TJ; White RD; Bruce GK; Hammill SC; Gersh BJ; Shen WK; Carter MA; Packer DL
    Resuscitation; 2004 Nov; 63(2):137-43. PubMed ID: 15531064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter defibrillator therapy: ten years experience in a medical center.
    Chen TE; Wang CC; Chang SH; Yeh SJ; Wu D
    Chang Gung Med J; 2008; 31(1):81-90. PubMed ID: 18419057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.